Preclinical pharmacokinetics and biodistribution of the dual adenosine A2A/A2B inhibitor muvadenant (M1069) in rats.

Nachtigall J, Maurer CK, Lecomte M, Schiemann K, Zaynagetdinov R, Reuter T, Scheible H

Open source

DOI
10.1080/00498254.2026.2720770
Published
2026 Sep 6
Container
Xenobiotica; the fate of foreign compounds in biological systems
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/00498254.2026.2720770,
  title = {Preclinical pharmacokinetics and biodistribution of the dual adenosine A2A/A2B inhibitor muvadenant (M1069) in rats.},
  author = {Nachtigall J and Maurer CK and Lecomte M and Schiemann K and Zaynagetdinov R and Reuter T and Scheible H},
  year = {2026},
  journal = {Xenobiotica; the fate of foreign compounds in biological systems},
  doi = {10.1080/00498254.2026.2720770},
  url = {https://doi.org/10.1080/00498254.2026.2720770}
}

RIS

TY  - JOUR
TI  - Preclinical pharmacokinetics and biodistribution of the dual adenosine A2A/A2B inhibitor muvadenant (M1069) in rats.
AU  - Nachtigall J
AU  - Maurer CK
AU  - Lecomte M
AU  - Schiemann K
AU  - Zaynagetdinov R
AU  - Reuter T
AU  - Scheible H
PY  - 2026
JO  - Xenobiotica; the fate of foreign compounds in biological systems
DO  - 10.1080/00498254.2026.2720770
UR  - https://doi.org/10.1080/00498254.2026.2720770
ER  - 

APA

J, N., CK, M., M, L., K, S., R, Z., T, R., & H, S. (2026). Preclinical pharmacokinetics and biodistribution of the dual adenosine A2A/A2B inhibitor muvadenant (M1069) in rats.. Xenobiotica; the fate of foreign compounds in biological systems. https://doi.org/10.1080/00498254.2026.2720770

Source records